[{"data":1,"prerenderedAt":285},["ShallowReactive",2],{"drug-clarithromycin":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":43,"contraindications":148,"warnings":199,"renal":242,"monitoring":252,"interactions":253,"review":254,"examples":257},"clarithromycin",1,{"fa":7,"en":8},"کلاریترومایسین","Clarithromycin","antibiotics",{"fa":11,"en":12},"ماکرولید","Macrolide",[14],{"name":15,"market":16},"Biaxin","US",[18,19],"clarithro","کلاریترو",[21,35],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"susp-125-5","suspension","oral","125 mg \u002F 5 mL",{"amount":27,"unit":28,"perVolumeMl":29},125,"mg",5,[16],[32],{"source":33,"section":34},"fda-clarithromycin-susp","3",{"id":36,"form":23,"route":24,"label":37,"concentration":38,"markets":40,"refs":41},"susp-250-5","250 mg \u002F 5 mL",{"amount":39,"unit":28,"perVolumeMl":29},250,[16],[42],{"source":33,"section":34},[44,73,90,110,127],{"id":45,"disease":46,"label":47,"population":50,"type":54,"unit":28,"dose":55,"refs":58,"limits":63,"durationDays":71},"pharyngitis","streptococcal-pharyngitis",{"fa":48,"en":49},"فارنژیت\u002Fتونسیلیت","Pharyngitis\u002Ftonsillitis",{"minAge":51},{"value":52,"unit":53},6,"month","weightBased",{"perKgPerDay":56,"dividedDoses":57},15,2,[59,61],{"source":33,"section":60},"2.4",{"source":33,"section":62},"8.4",{"maxPerDose":39,"refs":64},[65],{"source":66,"section":67,"note":68},"fda-clarithromycin-tab","2.2, Table 1",{"fa":69,"en":70},"دوز بزرگسال این عفونت: 250 mg هر ۱۲ ساعت","Adult dose for this infection: 250 mg every 12 h (\"up to the adult dose\")",{"min":72,"max":72},10,{"id":74,"disease":75,"label":76,"population":79,"type":54,"unit":28,"dose":81,"refs":82,"limits":85,"durationDays":89},"cap","community-acquired-pneumonia",{"fa":77,"en":78},"پنومونی اکتسابی","Community-acquired pneumonia",{"minAge":80},{"value":52,"unit":53},{"perKgPerDay":56,"dividedDoses":57},[83,84],{"source":33,"section":60},{"source":33,"section":62},{"maxPerDose":39,"refs":86},[87],{"source":66,"section":67,"note":88},{"fa":69,"en":70},{"min":72,"max":72},{"id":91,"disease":92,"label":93,"population":96,"type":54,"unit":28,"dose":98,"refs":99,"limits":102,"durationDays":109},"sinusitis","acute-bacterial-sinusitis",{"fa":94,"en":95},"سینوزیت ماگزیلاری حاد","Acute maxillary sinusitis",{"minAge":97},{"value":52,"unit":53},{"perKgPerDay":56,"dividedDoses":57},[100,101],{"source":33,"section":60},{"source":33,"section":62},{"maxPerDose":103,"refs":104},500,[105],{"source":66,"section":67,"note":106},{"fa":107,"en":108},"دوز بزرگسال این عفونت: 500 mg هر ۱۲ ساعت","Adult dose for this infection: 500 mg every 12 h (\"up to the adult dose\")",{"min":72,"max":72},{"id":111,"disease":112,"label":113,"population":116,"type":54,"unit":28,"dose":118,"refs":119,"limits":122,"durationDays":126},"skin","skin-soft-tissue-infection",{"fa":114,"en":115},"عفونت پوست بدون عارضه","Uncomplicated skin infection",{"minAge":117},{"value":52,"unit":53},{"perKgPerDay":56,"dividedDoses":57},[120,121],{"source":33,"section":60},{"source":33,"section":62},{"maxPerDose":39,"refs":123},[124],{"source":66,"section":67,"note":125},{"fa":69,"en":70},{"min":72,"max":72},{"id":128,"disease":129,"label":130,"population":133,"type":54,"unit":28,"dose":135,"refs":136,"durationDays":140,"notes":141},"aom","acute-otitis-media",{"fa":131,"en":132},"اوتیت مدیای حاد","Acute otitis media",{"minAge":134},{"value":52,"unit":53},{"perKgPerDay":56,"dividedDoses":57},[137,138],{"source":33,"section":60},{"source":33,"section":139},"1.6",{"min":72,"max":72},[142],{"text":143,"refs":146},{"fa":144,"en":145},"برچسب برای اوتیت مدیا دوز بزرگسال تعریف نکرده است؛ سقف «تا دوز بزرگسال» را با جدول بزرگسالان بسنجید.","The label defines no adult dose for otitis media; check \"up to the adult dose\" against the adult table.",[147],{"source":66,"section":67},[149,158,166,174,182,190],{"id":150,"severity":151,"text":152,"refs":155},"hypersensitivity","block",{"fa":153,"en":154},"حساسیت به کلاریترومایسین، اریترومایسین یا هر ماکرولید.","Hypersensitivity to clarithromycin, erythromycin or any macrolide.",[156],{"source":33,"section":157},"4.1",{"id":159,"severity":151,"text":160,"refs":163},"cisapride-pimozide",{"fa":161,"en":162},"مصرف همزمان با سیزاپراید یا پیموزاید (آریتمی کشنده).","Concomitant cisapride or pimozide (fatal arrhythmias).",[164],{"source":33,"section":165},"4.2",{"id":167,"severity":151,"text":168,"refs":171},"hepatic-history",{"fa":169,"en":170},"سابقه یرقان کلستاتیک\u002Fاختلال کبدی با کلاریترومایسین.","History of cholestatic jaundice\u002Fhepatic dysfunction with clarithromycin.",[172],{"source":33,"section":173},"4.3",{"id":175,"severity":151,"text":176,"refs":179},"colchicine",{"fa":177,"en":178},"همراه کلشی‌سین در نارسایی کلیه یا کبد.","With colchicine in renal or hepatic impairment.",[180],{"source":33,"section":181},"4.4",{"id":183,"severity":151,"text":184,"refs":187},"statins",{"fa":185,"en":186},"همراه لومیتاپید، لواستاتین یا سیمواستاتین.","With lomitapide, lovastatin or simvastatin.",[188],{"source":33,"section":189},"4.5",{"id":191,"severity":151,"rule":192,"text":194,"refs":197},"under-6-months",{"maxAge":193},{"value":52,"unit":53},{"fa":195,"en":196},"بی‌خطری سوسپانسیون زیر ۶ ماه ثابت نشده است.","Safety and effectiveness established only from 6 months.",[198],{"source":33,"section":62},[200,207,214,221,228,235],{"text":201,"refs":204},{"fa":202,"en":203},"واکنش‌های حساسیتی حاد شدید","Severe acute hypersensitivity reactions",[205],{"source":33,"section":206},"5.1",{"text":208,"refs":211},{"fa":209,"en":210},"طولانی شدن QT","QT prolongation",[212],{"source":33,"section":213},"5.2",{"text":215,"refs":218},{"fa":216,"en":217},"سمیت کبدی","Hepatotoxicity",[219],{"source":33,"section":220},"5.3",{"text":222,"refs":225},{"fa":223,"en":224},"عوارض جدی در مصرف همزمان با داروهای دیگر","Serious adverse reactions with concomitant drugs",[226],{"source":33,"section":227},"5.4",{"text":229,"refs":232},{"fa":230,"en":231},"اسهال مرتبط با کلستریدیوم دیفیسیل","Clostridium difficile-associated diarrhea",[233],{"source":33,"section":234},"5.6",{"text":236,"refs":239},{"fa":237,"en":238},"تشدید میاستنی گراویس","Exacerbation of myasthenia gravis",[240],{"source":33,"section":241},"5.8",[243],{"egfrBelow":244,"severity":245,"text":246,"refs":249},30,"warn",{"fa":247,"en":248},"کلیرانس کمتر از ۳۰: دوز ۵۰٪ کاهش یابد.","CrCl \u003C30 mL\u002Fmin: reduce dose by 50%.",[250],{"source":33,"section":251},"2.6",[],[],{"status":255,"reviewer":256,"date":256},"unverified",null,[258,263,268,273,277,280],{"regimen":45,"formulation":22,"input":259,"expect":260},{"ageYears":57,"weightKg":72},{"perDose":261,"mlPerDose":262},75,3,{"regimen":45,"formulation":36,"input":264,"expect":267},{"ageYears":265,"weightKg":266},12,40,{"perDose":39},{"regimen":74,"formulation":36,"input":269,"expect":271},{"ageYears":52,"weightKg":270},20,{"perDose":272},150,{"regimen":91,"formulation":36,"input":274,"expect":275},{"ageYears":72,"weightKg":266},{"perDose":276,"mlPerDose":52},300,{"regimen":111,"formulation":22,"input":278,"expect":279},{"ageYears":57,"weightKg":72},{"perDose":261},{"regimen":128,"formulation":22,"input":281,"expect":282},{"ageYears":57,"weightKg":265},{"perDose":283,"mlPerDose":284},90,3.6,1792078533391]